Assessing the Effects of a Topically Applied Cream to Clitoral Blood Flow

NCT01085981 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Female Sexual Dysfunction

Interventions

DRUG: arginine 20%, nicotinamide .01%, niacin.1%, in LipodermPG 50%
DRUG: Topical study cream
DRUG: GRAS cream

Sponsor

East Suburban Ob Gyn